8 results on '"Nakahira M"'
Search Results
2. Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.
- Author
-
Yokoyama K, Wasano K, Sasaki K, Machida R, Nakahira M, Kitamura K, Sakagami T, Takeshita N, Ohkoshi A, Suzuki M, Tateya I, Morishita Y, Sekimizu M, Nakayama M, Koyama T, Shibata H, Miyamaru S, Kiyota N, Hanai N, and Homma A
- Subjects
- Humans, Japan, Male, Aged, Female, Middle Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Antineoplastic Combined Chemotherapy Protocols economics, Adult, Retrospective Studies, Neoplasm Metastasis, Palliative Care economics, Squamous Cell Carcinoma of Head and Neck drug therapy, Squamous Cell Carcinoma of Head and Neck economics, Squamous Cell Carcinoma of Head and Neck secondary, Head and Neck Neoplasms drug therapy, Head and Neck Neoplasms economics, Head and Neck Neoplasms pathology, Neoplasm Recurrence, Local drug therapy
- Abstract
Background: Over the last decade, novel anticancer drugs have improved the prognosis for recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN). However, this has increased healthcare expenditures and placed a heavy burden on patients and society. This study investigated the frequency of use and costs of select palliative chemotherapy regimens in Japan., Methods: From July 2021 to June 2022 in 54 healthcare facilities, we gathered data of patients diagnosed with RM-SCCHN and who had started first-line palliative chemotherapy with one of eight commonly used regimens. Patients with nasopharyngeal carcinomas were excluded. The number of patients receiving each regimen and the costs of each regimen for the first month and per year were tallied., Results: The sample comprised 907 patients (674 were < 75 years old, 233 were ≥ 75 years old). 330 (36.4%) received Pembrolizumab monotherapy, and 202 (22.3%) received Nivolumab monotherapy. Over 90% of patients were treated with immune checkpoint inhibitors as monotherapy or in combination with chemotherapy. Treatment regimens' first-month costs were 612 851-849 241 Japanese yen (JPY). The cost of standard palliative chemotherapy until 2012 was about 20 000 JPY per month. The incremental cost over the past decade is approximately 600 000-800 000 JPY per month, a 30- to 40-fold increase in the cost of palliative chemotherapy for RM-SCCHN., Conclusion: First-line palliative chemotherapy for RM-SCCHN exceeds 600 000 JPY monthly. Over the last decade, the prognosis for RM-SCCHN has improved, but the costs of palliative chemotherapy have surged, placing a heavy burden on patients and society., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
3. Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008.
- Author
-
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, Mitani H, Hirayama Y, Onozawa Y, Nishio N, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Uemura H, Shiga K, Nakahira M, Asakage T, Saito Y, Sasaki K, Kitabayashi R, Ishikura S, Nishimura Y, and Tahara M
- Subjects
- Humans, Male, Female, Middle Aged, Risk Factors, Incidence, Aged, Chemoradiotherapy adverse effects, Adult, Hypothyroidism etiology, Hypothyroidism epidemiology, Head and Neck Neoplasms radiotherapy, Head and Neck Neoplasms therapy
- Abstract
Background and Purpose: Hypothyroidism is a recognized late adverse event following radiotherapy for head and neck cancer (HNC). In the JCOG1008 trial, we treated patients with high-risk HNC with postoperative chemoradiotherapy. We aimed to elucidate factors associated with hypothyroidism by analyzing the JCOG1008 data., Materials and Methods: In 2012-2018, 261 patients from 28 institutions were enrolled in JCOG1008. Thyroid function tests were conducted to assess hypothyroidism, including free thyroxine (FT4) and thyroid-stimulating hormone assays. Hypothyroidism was defined as Grade 2 or higher in CTCAE v4.0. Various clinical and dosimetric parameters were analyzed. In radiotherapy, there were no dose constraints for the thyroid. Multivariable analysis was conducted on these variables to identify predictive factors for hypothyroidism., Results: The analysis included 162 patients (57 with 3D-CRT and 105 with IMRT), with a median follow-up of 4.7 years (0.3-9.3 years). Among these, 27 (16.7 %) developed hypothyroidism within 2 years after radiotherapy. In a multivariable analysis, the weekly cisplatin [OR=7.700 (CI: 1.632-36.343, p = 0.010)] and baseline FT4 [OR=0.009 (CI: <0.001-0.313, p = 0.010)] were significantly associated with hypothyroidism in the IMRT group. Regarding dosimetric characteristics, V
60Gy [OR=1.069 (CI: 0.999-1.143, p = 0.054)] was potentially associated with the development of hypothyroidism., Conclusion: The study revealed that the incidence of hypothyroidism within 2 years after postoperative chemoradiotherapy for high-risk HNC was 16.7 % based on analytical results from prospective clinical trials., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
4. Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma.
- Author
-
Matsumura S, Kaira K, Kuba K, Inoue H, Hamada M, Yamazaki T, Nakahira M, and Ebihara Y
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Neutrophils immunology, Aged, 80 and over, Biomarkers, Tumor blood, Prognosis, Immune Checkpoint Inhibitors therapeutic use, Lymphocytes immunology, Nutrition Assessment, Nutritional Status, Squamous Cell Carcinoma of Head and Neck immunology, Squamous Cell Carcinoma of Head and Neck therapy, Squamous Cell Carcinoma of Head and Neck pathology, Squamous Cell Carcinoma of Head and Neck drug therapy, Squamous Cell Carcinoma of Head and Neck mortality, Head and Neck Neoplasms immunology, Head and Neck Neoplasms pathology, Head and Neck Neoplasms therapy, Head and Neck Neoplasms drug therapy, Head and Neck Neoplasms blood, Immunotherapy methods
- Abstract
Background/aim: Immune checkpoint inhibitors (ICIs) are the standard treatment for advanced head and neck squamous cell carcinoma (HNSCC). Programmed death-ligand 1 (PD-L1) is clinically assessed before initiating ICIs; however, there are no established biomarkers for predicting the response to immunotherapy. In this study, inflammatory and nutritional parameters were examined to determine the therapeutic outcomes of ICIs for HNSCC., Patients and Methods: Sixty-five patients with metastatic or recurrent HNSCC who received programmed death-1 (PD-1) blockade were enrolled. Inflammatory and nutritional indices were correlated with patient outcomes, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and prognostic nutritional index (PNI)., Results: Patients aged <70 years were significantly associated with a high NLR, whereas those with a performance status of 2 or 3 were closely related to a high NLR, high SII, and low PNI. Although all patients achieved an objective response rate of 24.6% and a disease control rate of 36.9%, the NLR, PLR, SII, and PNI values were not significantly different between responders and non-responders. Univariate analysis showed that the NLR, PLR, SII, and PNI were significant predictors of progression-free survival (PFS) and overall survival (OS). Multivariate analysis identified PNI as an independent predictor of PFS and OS., Conclusion: PNI, as a nutritional marker, was identified as a significant predictor of outcomes following PD-1 blockade administration in patients with advanced HNSCC, compared to inflammatory markers, such as NLR, PLR, and SII., (Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. The Effects of Reiki on the Stress of Japanese Nurses: Mixed Methods Pilot Study.
- Author
-
Morimitsu Y, Nakahira M, and Nishikawa A
- Abstract
Purpose: To identify the effects of Reiki on stress among Japanese nurses. Design: Mixed method and intervention design. Method: A nonprobability snowball sampling was used. Twenty-one nurses were invited to receive the Reiki intervention. Physical responses were measured by pulse rate, respiration rate, blood pressure rate, and salivary α-amylase activity pre- and postintervention. Psychological responses were evaluated by the mood dimensions and Total Mood Disturbance of the Profile of Mood States 2nd Edition. To obtain qualitative data, semistructured interviews were conducted after the intervention, and a web-based questionnaire was completed the following day. Findings: Twenty-one participants completed the study, and results indicated that the Reiki intervention significantly improved psychological stress reactions. No significant differences were found in physical stress. Two categories were identified from qualitative data: "positive effects" and "negative effects". Codes including "warm," "body feeling more comfortable," and "stress awareness" emerged as the positive effects. No adverse events were indicated. Conclusion: The results are the first step toward holistic nursing care in Japan and quantitative and qualitative data confirmed that Reiki improved the psychological aspect of stress responses of Japanese nurses.
- Published
- 2024
- Full Text
- View/download PDF
6. 3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer.
- Author
-
Takahashi M, Nakazawa K, Usami Y, Natsuyama Y, Tsukamoto Y, Suzuki J, Asami S, Inoue H, Matsumura S, Nakahira M, Saito T, Kato S, Okada Y, Tajima H, Kozawa E, and Baba Y
- Abstract
Background: To evaluate the efficacy of a catheter system using a 3-Fr sheath with a steerable microcatheter through right upper limb artery access for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) to treat right maxillary sinus squamous cell carcinoma (MS-SCC)., Material and Methods: We retrospectively studied 46 sessions in eight patients treated between November 2020 and February 2023 using the catheter system briefly described below. A 3-Fr sheath was inserted into the distal radial, conventional radial, or brachial arteries. A coaxial catheter system with a 2.9-Fr steerable microcatheter and a 1.9-Fr microcatheter was advanced into the brachiocephalic artery. The right common carotid artery was selected by bending the tip of the steerable microcatheter. Coil embolization and intra-arterial cisplatin infusion after selecting each external carotid artery branch were achieved using this catheter system., Results: Cisplatin infusion and coil embolization were successful in all sessions. Arterial occlusion at the sheath insertion sites was found in 29.4% (5/17) of the distal radial arteries and 33.3% (3/9) of the conventional radial arteries. No other major complications were observed during the procedure., Conclusion: Using a 3-Fr catheter system with a steerable microcatheter through right upper limb artery access is a feasible method for RADPLAT in treating right MS-SCC.
- Published
- 2024
- Full Text
- View/download PDF
7. Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
- Author
-
Ariizumi Y, Hanai N, Asakage T, Seto A, Tomioka T, Miyabe J, Kessoku H, Mukaigawa T, Omura G, Teshima M, Nishikawa D, Saito Y, Asada Y, Fujisawa T, Makino T, Nishino H, Sano D, Nakahira M, Tokashiki K, Uemura H, Ueda T, Sakai A, Masuda M, Tsujikawa T, Hiei Y, Nishio N, Matsui H, Kiyota N, and Homma A
- Subjects
- Humans, Thyroidectomy adverse effects, Neck Dissection, Retrospective Studies, Lymph Node Excision adverse effects, Hypopharyngeal Neoplasms surgery, Hypopharyngeal Neoplasms pathology, Pyriform Sinus surgery, Pyriform Sinus pathology, Hypoparathyroidism etiology, Thyroid Neoplasms surgery, Thyroid Neoplasms pathology
- Abstract
Background: Total pharyngolaryngectomy (TPL) is standard treatment for hypopharyngeal cancer. However, extensive thyroidectomy and paratracheal nodal dissection (PTND) can cause hypoparathyroidism. We sought to determine the optimum extent of resection., Methods: We analyzed the clinicopathological information of 161 pyriform sinus cancer patients undergoing TPL from 25 Japanese institutions. Rates of recurrence and risk factors for hypoparathyroidism, as well as incidence of pathological contralateral level VI nodal metastasis and stomal recurrence, were investigated., Results: The extent of thyroidectomy and nodal dissection were not independent risk factors for recurrence. Incidences of contralateral level VI nodal involvement and stomal recurrence were 1.8% and 1.2%, respectively. Patients undergoing hemithyroidectomy/ipsilateral PTND did not develop stomal recurrence and had the lowest incidence of hypoparathyroidism. Prognosis in patients without tracheostomy prior to hemithyroidectomy/ipsilateral PTND was comparable to that with more extensive resections., Conclusions: Hemithyroidectomy/ipsilateral PTND may be sufficient for pyriform sinus cancer cases without tracheostomy., (© 2023 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
8. Follicular adenoma with a papillary architecture originating from an ectopic thyroid gland: a case report.
- Author
-
Kuba K, Kawasaki T, Enoki Y, Inoue H, Matsumura S, Yamazaki T, Ebihara Y, Nakahira M, and Sugasawa M
- Subjects
- Female, Humans, Aged, Diagnosis, Differential, Carcinoma, Papillary surgery, Carcinoma, Papillary pathology, Thyroid Neoplasms pathology, Thyroid Dysgenesis diagnosis, Adenoma diagnostic imaging, Adenoma surgery
- Abstract
Background: Follicular adenomas with papillary architecture are rare tumors of thyroid origin and are composed of completely encapsulated follicular cells with a papillary architecture lacking the nuclear characteristics of papillary carcinoma. Herein, we present a case of follicular adenoma with papillary architecture originating from an ectopic thyroid gland, diagnosed from a mass in the submandibular region., Case Presentation: A 70-year-old woman was referred to our hospital with the chief complaint of a painless left submandibular mass that had been present for one year. The patient underwent left submandibular dissection for therapy and diagnosis. Microscopically, papillary lesions with fibrovascular cores were observed in the interior, and the epithelial cells were cylindrical in shape with eosinophilic cytoplasm, round or oval nuclei, with no pathological features, leading to a diagnosis of papillary carcinoma or follicular carcinoma. The mass was diagnosed as a follicular thyroid adenoma with papillary architecture. This is the first report of a follicular adenoma with a papillary architecture originating from an ectopic thyroid gland., Conclusion: This experience suggests that follicular adenoma should be included in the differential diagnosis of ectopic thyroid tumors., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.